PAPER Sakakibara S, Hashimoto R, Katayama T, Kenjyo M, Yokokawa Y, Saito Y, Hirakawa A, Ito M, Nakamura T, Hara K, Hashizume A, Aiba I, Inukai A, Katsuno M
SEARCH RESULTS
1401 RESULTS
PAPER Peters R, Anderson CS
Advancing dementia prevention through effective blood pressure control.
Lancet Neurol. 2020 Jan;19(1):25-27. Epub 2019 Nov 6 PubMed: 31706888PAPER Robinson EJ, Aguiar S, Smidt MP, van der Heide LP
MCL1 as a Therapeutic Target in Parkinson's Disease?
Trends Mol Med. 2019 Dec;25(12):1056-1065. Epub 2019 Nov 6 PubMed: 31706839PAPER Ling L, Jiang Y, Liu Y, Li H, Bari A, Ullah R, Xue J
Role of gold nanoparticle from Cinnamomum verum against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mice model.
J Photochem Photobiol B. 2019 Dec;201:111657. Epub 2019 Oct 28 PubMed: 31706085PAPER Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
Neurobiol Dis. 2020 Feb;134:104671. Epub 2019 Nov 6 PubMed: 31706021PAPER Ramirez-Garcia G, Galvez V, Diaz R, Bayliss L, Fernandez-Ruiz J, Campos-Romo A
Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
Eur J Neurosci. 2019 Nov 9; PubMed: 31705594PAPER Ko YH, Kwon SH, Kim SK, Lee BR, Hur KH, Kim YJ, Kim SE, Lee SY, Jang CG
Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells.
Arch Pharm Res. 2019 Dec;42(12):1081-1091. Epub 2019 Nov 8 PubMed: 31705299PAPER Ellajosyula R, Narayanan J, Patterson K
Striking loss of second language in bilingual patients with semantic dementia.
J Neurol. 2020 Feb;267(2):551-560. Epub 2019 Nov 8 PubMed: 31705289PAPER Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J, Simons C, Patil K, Gaifullina A, Mannal N, Dragicevic E, Spaich D, Müller S, Nemeth J, Hollmann H, Deuter N, Mousba Y, Kubisch C, Poetschke C, Striessnig J, Pongs O, Schneider T, Wade-Martins R, Patel S, Parlato R, Frank T, Kloppenburg P, Liss B
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease.
Nat Commun. 2019 Nov 8;10(1):5094. PubMed: 31704946PAPER Baxa M, Levinska B, Skrivankova M, Pokorny M, Juhasova J, Klima J, Klempir J, Motlı K J, Juhas S, Ellederova Z
Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease.
Dis Model Mech. 2019 Dec 12;13(2) PubMed: 31704691PAPER Oremus M, Tyas SL, Maxwell CJ, Konnert C, O'Connell ME, Law J
Social support availability is positively associated with memory in persons aged 45-85 years: A cross-sectional analysis of the Canadian Longitudinal Study on Aging.
Arch Gerontol Geriatr. 2020 Jan - Feb;86:103962. Epub 2019 Oct 9 PubMed: 31704625PAPER Samoudi G, Nilsson A, Carlsson T, Bergquist F
c-Fos Expression after Stochastic Vestibular Stimulation and Levodopa in 6-OHDA Hemilesioned Rats.
Neuroscience. 2020 Jan 1;424:146-154. Epub 2019 Nov 6 PubMed: 31704349PAPER Rösler TW, Costa M, Höglinger GU
Disease-modifying strategies in primary tauopathies.
Neuropharmacology. 2020 May 1;167:107842. Epub 2019 Nov 5 PubMed: 31704274PAPER Huebecker M, Moloney EB, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, Platt FM
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
Mol Neurodegener. 2019 Nov 8;14(1):40. PubMed: 31703585Juan Ignacio Caracotche
Trelew, Argentina
Current Filters
- Date Range : Nov 2019 to Dec 2019 x